Biomaterial Database

T-cell prolymphocytic leukemia presenting as ascites. 2019

Sjoerd J F Hermans, and Yorick Sandberg

Maasstad Ziekenhuis.

UI	MeSH Term	Description	Entries
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D001201	Ascites	Accumulation or retention of free fluid within the peritoneal cavity.
D001706	Biopsy	Removal and pathologic examination of specimens from the living body.	Biopsies
D015415	Biomarkers	Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.	Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015461	Leukemia, Prolymphocytic, T-Cell	A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.	Leukemia, T-Cell, Chronic,T-Cell Prolymphocytic Leukemia,Leukemia, Lymphocytic, Chronic, T Cell,Leukemia, Lymphocytic, Chronic, T-Cell,Leukemia, T Cell, Chronic,Lymphocytic Leukemia, T Cell, Chronic,Lymphocytic Leukemia, T-Cell, Chronic,T-Cell Leukemia, Chronic,T-Lymphocytic Leukemia, Chronic,Leukemia, T-Cell Prolymphocytic,Leukemias, T-Cell Prolymphocytic,Prolymphocytic Leukemia, T-Cell,Prolymphocytic Leukemias, T-Cell,T Cell Prolymphocytic Leukemia,T-Cell Prolymphocytic Leukemias
D016130	Immunophenotyping	Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.	Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D020732	Cytogenetic Analysis	Examination of CHROMOSOMES to diagnose, classify, screen for, or manage genetic diseases and abnormalities. Following preparation of the sample, KARYOTYPING is performed and/or the specific chromosomes are analyzed.	Cytogenetic Techniques,Molecular Cytogenetic Techniques,Cytogenetic Technics,Molecular Cytogenetic Technics,Analyses, Cytogenetic,Analysis, Cytogenetic,Cytogenetic Analyses,Cytogenetic Technic,Cytogenetic Technic, Molecular,Cytogenetic Technics, Molecular,Cytogenetic Technique,Cytogenetic Technique, Molecular,Cytogenetic Techniques, Molecular,Molecular Cytogenetic Technic,Molecular Cytogenetic Technique,Technic, Cytogenetic,Technic, Molecular Cytogenetic,Technics, Cytogenetic,Technics, Molecular Cytogenetic,Technique, Cytogenetic,Technique, Molecular Cytogenetic,Techniques, Cytogenetic,Techniques, Molecular Cytogenetic

Related Publications

Sjoerd J F Hermans, and Yorick Sandberg

T-cell prolymphocytic leukemia presenting as red eye.

January 2011, Middle East African journal of ophthalmology,

Sjoerd J F Hermans, and Yorick Sandberg

Masquerade syndrome: T-cell prolymphocytic leukemia presenting as panuveitis.

August 2001, American journal of ophthalmology,

Sjoerd J F Hermans, and Yorick Sandberg

T-cell prolymphocytic leukemia presenting as an ear canal mass.

November 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,

Sjoerd J F Hermans, and Yorick Sandberg

T-cell prolymphocytic leukemia with cutaneous involvement as the presenting feature.

March 2012, Indian journal of dermatology,

Sjoerd J F Hermans, and Yorick Sandberg

Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.

July 2021, Journal of cutaneous pathology,

Sjoerd J F Hermans, and Yorick Sandberg

T-cell prolymphocytic leukemia.

January 2013, Proceedings (Baylor University. Medical Center),

Sjoerd J F Hermans, and Yorick Sandberg

T-cell Prolymphocytic Leukemia.

April 2017, Hematology/oncology clinics of North America,